Xiao-Qin Zhang

Comprehensive analysis of pyroptotic gene prognostic signatures associated with tumor immune microenvironment and genomic mutation in breast cancer

Yi Zhou, L. Shen, Yanhui Zhu, 2022, Frontiers in Immunology.

Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple‐negative breast cancer

Haitao Luo, Yanhui Zhu, Xiaoan Liu, 2022, Cancer medicine.

Long non-coding RNA ABHD11-AS1 facilitates the progression of cervical cancer by competitively binding to miR-330-5p and upregulating MARK2.

Jian Yang, Shunyu Hou, Xiao-Qin Zhang, 2021, Experimental cell research.

Geranylgeranyl Transferase-I Knockout Inhibits Oxidative Injury of Vascular Smooth Muscle Cells and Attenuates Diabetes-Accelerated Atherosclerosis

Jian Yang, Guo-Ping Chen, Xiao-Qin Zhang, 2020, Journal of diabetes research.

MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.

Huiqing Zhang, Yonggang Liang, Xiaoqiang Zhang, 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

LHX2 Is a Potential Biomarker and Associated with Immune Infiltration in Breast Cancer

Yanhui Zhu, Xiaoan Liu, Junzhe Yang, 2023, Cancers.

Crosstalk of RNA methylation writers defines tumor microenvironment and alisertib resistance in breast cancer

L. Shen, Yanhui Zhu, Changyuan Zhai, 2023, Frontiers in endocrinology.

Comprehensive evaluation of cell death-related genes as novel diagnostic biomarkers for breast cancer

Yanhui Zhu, Junzhe Yang, Xiafei Yu, 2023, Heliyon.

MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.

Huiqing Zhang, Yonggang Liang, Xianju He, 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.